This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Dr. Anne Chevrel, PhD
Head of Discovery and Technology at Mabqi
Speaker

Profile

Anne Chevrel joined Mabqi in 2023 as Head of Discovery, where she leads the design and development of innovative antibody-based therapeutics across internal and partnered programs. Her work integrates advanced AI-assisted discovery platforms (combining Phage & Yeast displays) and enabling technologies to drive therapeutic innovation. Trained in protein engineering and biotechnology, she holds a PhD and brings over a decade of experience leading discovery and early development programs in biologics.

Agenda Sessions

  • Preclinical Progress of Novel Tumor Specific Anti CD30 ADC Designed to Bypass Antigen Sink Effect

    15:25